Method for producing sphingoid base or sphingolipid
US-2018179563-A1 · Jun 28, 2018 · US
US11111511B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11111511-B2 |
| Application number | US-201815898369-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 16, 2018 |
| Priority date | Aug 24, 2015 |
| Publication date | Sep 7, 2021 |
| Grant date | Sep 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for producing an objective substance such as phytosphingosine and sphinganine using yeast is provided. An objective substance is produced by cultivating yeast having an ability to produce the objective substance and modified so that the expression and/or activities of proteins encoded by LCB4 and CKA2 genes are reduced in a culture medium, and collecting the objective substance from cells of the yeast and/or the culture medium.
Opening claim text (preview).
We claim: 1. A method for producing an objective substance, the method comprising: cultivating yeast having an ability to produce the objective substance in a culture medium; and collecting the objective substance from cells of the yeast and/or the culture medium, wherein the yeast has been modified so that the expression and/or activities of proteins encoded by LCB4, CKA2, and ORM2 genes are reduced, and wherein the objective substance is selected from the group consisting of phytosphingosine (PHS) and sphinganine (DHS), and wherein the culture medium contains cyclodextrin. 2. The method according to claim 1 , wherein the activities of the proteins are reduced by attenuating the expression of the LCB4, CKA2, and ORM2 gene, or by disrupting the LCB4, CKA2, and ORM2 gene. 3. The method according to claim 1 , wherein the activities of the proteins are reduced by deletion of the LCB4, CKA2, and ORM2 genes. 4. The method according to claim 1 , wherein the protein encoded by the LCB4 gene is a protein defined in (A), (B), or (C) mentioned below: (A) a protein comprising the amino acid sequence of SEQ ID NO: 10; (B) a protein comprising the amino acid sequence of SEQ ID NO: 10 but including substitution, deletion, insertion, and/or addition of 1 to 10 amino acid residues, and having sphingoid base kinase activity; (C) a protein comprising an amino acid sequence showing an identity of 90% or higher to the amino acid sequence of SEQ ID NO: 10, and having sphingoid base kinase activity. 5. The method according to claim 1 , wherein the protein encoded by the CKA2 gene is a protein defined in (A), (B), or (C) mentioned below: (A) a protein comprising the amino acid sequence of SEQ ID NO: 16; (B) a protein comprising the amino acid sequence of SEQ ID NO: 16 but including substitution, deletion, insertion, and/or addition of 1 to 10 amino acid residues, and having casein kinase 2 activity; (C) a protein comprising an amino acid sequence showing an identity of 90% or higher to the amino acid sequence of SEQ ID NO: 16, and having casein kinase 2 activity. 6. The method according to claim 1 , wherein the yeast has further been modified so that the expression and/or activity or activities of one or more proteins selected from proteins encoded by LCB5, ELO3, and CHA1 genes are reduced. 7. The method according to claim 6 , wherein the activity or activities of the one or more proteins are reduced by attenuating the expression of the respective genes encoding the one or more proteins, or by disrupting the respective genes encoding the one or more proteins. 8. The method according to claim 6 , wherein the activity or activities of the one or more proteins are reduced by deletion of the respective genes encoding the one or more proteins. 9. The method according to claim 1 , wherein the yeast has further been modified so that the expression and/or activity or activities of one or more proteins selected from proteins encoded by LCB1, LCB2, TSC10, and SUR2 genes are increased. 10. The method according to claim 9 , wherein the activity or activities of the one or more proteins are increased by increasing the expression of the respective genes encoding the one or more proteins. 11. The method according to claim 9 , wherein the expression of the gene(s) is increased by increasing the copy number of the gene(s), and/or by modifying an expression control sequence of the gene(s). 12. The method according to claim 1 , wherein the phytosphingosine is selected from the group consisting of C16 PHS, C18 PHS, C20 PHS, C18:1 PHS, C20:1 PHS, 4-(hydroxymethyl)-2-methyl-6-tetradecanyl-1,3-oxazinan-5-ol, and 4-(hydroxymethyl)-2-methyl-6-hexadecanyl-1,3-oxazinan-5-ol. 13. The method according to claim 1 , wherein the yeast belongs to the genus Saccharomyces. 14. The method according to claim 1 , wherein the yeast is Saccharomyces cerevisiae. 15. The method according to claim 1 , wherein the yeast is able to produce and accumulate the objective substance in a culture medium or cells of the yeast in an amount larger than that obtainable with a non-modified strain.
transferring phosphorus containing groups, e.g. kinases (2.7) · CPC title
Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase · CPC title
Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases · CPC title
by using fungi · CPC title
Sphinganine kinase (2.7.1.91) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.